News & Updates

Early-onset AD implicated in paediatric uveitis

10 Apr 2025

Children with early-onset atopic dermatitis (AD) face an increased risk of uveitis, as reported in a study.

Early-onset AD implicated in paediatric uveitis

10 Apr 2025

Two-ingredient diaper wipes gentle on skin affected by eczema

05 Apr 2025 by

Wipes formulated with purified water plus fruit extract for sensitive skin are safe to use on babies with eczema-prone skin or active eczema, according to a study.

Two-ingredient diaper wipes gentle on skin affected by eczema

05 Apr 2025

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

03 Apr 2025 by

Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

03 Apr 2025

Early-onset AD tied to higher risk of atopic march in children

02 Apr 2025

Children with early-onset atopic dermatitis (AD) are at increased odds of developing atopic march conditions compared with those with early-onset AD, reveals a study.

Early-onset AD tied to higher risk of atopic march in children

02 Apr 2025

Biosimilar as safe, effective as ustekinumab in plaque psoriasis

31 Mar 2025

The biosimilar BAT2206 demonstrates similar efficacy, safety, pharmacokinetics, and immunogenicity to its reference drug, ustekinumab (UST), in a recent phase III trial.

Biosimilar as safe, effective as ustekinumab in plaque psoriasis

31 Mar 2025

Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab

28 Mar 2025 by

The use of lebrikizumab improves the symptoms of moderate-to-severe atopic dermatitis (AD) in patients previously treated with dupilumab, reports a study presented at AAD 2025.

Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab

28 Mar 2025

Skin fairness creams not fair to the kidneys

28 Mar 2025 by

A recent review integrates multiple research findings and turns the spotlight on the growing nephrotoxic threat posed by skin-whitening creams.

Skin fairness creams not fair to the kidneys

28 Mar 2025

Remibrutinib improves sleep, daily activities in patients with CSU

28 Mar 2025 by

Treatment with remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, improved sleep and daily activities in patients with chronic spontaneous urticaria (CSU), according to two phase III REMIX-1 and -2 studies presented at AAD 2025.

Remibrutinib improves sleep, daily activities in patients with CSU

28 Mar 2025

Apremilast boasts long-term improvement in PPP

27 Mar 2025 by

Patients with palmoplantar pustulosis (PPP) treated with apremilast show improvements at week 16, with continued treatment resulting in maintained or further improvement at week 52, according to a study presented at AAD 2025. No new safety concerns have been observed.

Apremilast boasts long-term improvement in PPP

27 Mar 2025

Baricitinib tied to hair regrowth in adolescents with severe AA

26 Mar 2025 by

Once-daily treatment with baricitinib resulted in clinically meaningful improvements in hair regrowth on the scalp, eyebrows, and eyelashes among adolescent patients with severe alopecia areata (AA), according to the BRAVE-AA-PEDS trial presented at AAD 2025.

Baricitinib tied to hair regrowth in adolescents with severe AA

26 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Early-onset AD implicated in paediatric uveitis

Early-onset AD implicated in paediatric uveitis

Two-ingredient diaper wipes gentle on skin affected by eczema

Two-ingredient diaper wipes gentle on skin affected by eczema

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

Is vitiligo as side effect a good sign for cancer patients on immunotherapy?

Early-onset AD tied to higher risk of atopic march in children

Early-onset AD tied to higher risk of atopic march in children

Biosimilar as safe, effective as ustekinumab in plaque psoriasis

Biosimilar as safe, effective as ustekinumab in plaque psoriasis

Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab

Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab

Skin fairness creams not fair to the kidneys

Skin fairness creams not fair to the kidneys

Remibrutinib improves sleep, daily activities in patients with CSU

Remibrutinib improves sleep, daily activities in patients with CSU

Apremilast boasts long-term improvement in PPP

Apremilast boasts long-term improvement in PPP

Baricitinib tied to hair regrowth in adolescents with severe AA

Baricitinib tied to hair regrowth in adolescents with severe AA